Despite certain study participants having lower risk factors associated with developing cardiovascular disease, including being younger and a higher proportion who had never smoked, 12.7% of participants developed cardiovascular disease after four years of follow-up.
Despite certain study participants having lower risk factors associated with developing cardiovascular disease, including being younger and a higher proportion who had never smoked, 12.7% of participants developed cardiovascular disease after four years of follow-up.
Read More
The risk of developing COPD could be 50% greater for women as it is for men, according to a new diagnostic method utilized by researchers from Lund University Sweden.
Read MoreCompared to COPD, asthma, or cystic fibrosis, Alpha-1 antitrypsin deficiency lung disease is not well known, but dedicated researchers and RTs continue to support patients and work towards finding new treatment options.
Read More
Individuals with single-gene mutations that decrease levels of the protein alpha-1 antitrypsin are at high risk for emphysema at a young age. Researchers have attained sustained in vivo expression of normal human alpha-1 antitripsin—and at levels that improved emphysema in mice.
Read More
Thanks to the Alpha-1 Foundation, many COPD patients with alpha-1 antitrypsin deficiency have been properly diagnosed and treated, but the work is far from over.
Read More
For the 12th year in a row, US News & World Report named National Jewish Health, Denver, the best respiratory hospital in the nation.
Read More
RT spoke with ZLB Behring, the company that manufactures the alpha-1 therapy Zemaira, to gain a better understanding of alpha-1 and the treatments available.
Read More
Air travel is complicated for oxygen-dependent people, involving fees that can double the cost of the ticket and periods of time without access to oxygen. Patient and professional advocacy efforts might help.
Read More
